BioCentury
ARTICLE | Clinical News

Flublok Quadrivalent: Phase III data

July 27, 2015 7:00 AM UTC

Top-line data from a double-blind, U.S. Phase III trial in about 9,000 healthy volunteers ages >=50 showed that intramuscular Flublok Quadrivalent reduced the number of subjects who contracted the flu...